Joint (JYNT)
Nasdaq Market Closed
The Joint Corp. is a U.S. chiropractic clinic operator and franchisor built around a retail healthcare model. Through The Joint Chiropractic brand, the company develops, owns, supports and franchises clinics that provide chiropractic care in accessible retail locations across the United States.
The company’s clinics are designed to make chiropractic treatment more convenient for consumers. Patients can typically seek care without the traditional insurance-driven structure common in many healthcare settings, and the brand emphasizes walk-in access, recurring wellness visits and affordable membership or package-based options. Chiropractors in the network evaluate patients and create treatment plans intended to address pain, mobility issues and ongoing preventive care needs.
The Joint’s business model combines franchising with company-owned and managed clinics. Its franchise operations generate revenue by granting franchisees access to the company’s brand, operating system, training, marketing support and other intellectual property. The model allows the company to expand its clinic footprint through independent operators while maintaining a standardized consumer experience under a national brand.
For investors, The Joint represents exposure to the intersection of consumer healthcare, wellness services and franchised retail. Demand is tied to patient traffic, clinic openings, franchisee performance, brand awareness and broader consumer willingness to pay out of pocket for routine chiropractic care. The company operates in a fragmented chiropractic market, where its distinctive positioning comes from creating a recognizable, scaled clinic network rather than relying solely on traditional solo-practice care.
Last updated
- Market Cap
- 123.59M
- P/E
- 38.16
- P/FCF
- 46.53
- P/S
- 2.18
- Enterprise Value
- 103.94M
- Sector
- Financials
- Industry
- Patent Owners and Lessors
- Address
- 16767 N PERIMETER DRIVE, SCOTTSDALE, AZ, 85260
The Joint Corp. Signs Asset Purchase Agreement to Sell 22 Corporate Clinics in the Southeast and Delivers Notice to Terminate APA for 45 Clinics in California
The Joint Corp. Expects to Restate Full Year 2024 and First Quarter 2025 Financial Statements due to Overestimated Noncash Impairment Charges
Valneva (VALN) Gets EC's Approval on Chikungunya Vaccine - Zacks Investment Research
Neuronetics (STIM) Expands NeuroStar Portfolio With New Launch
National Vision (EYE) Gains Market Share Despite Macro Woes
Neogen (NEOG) Expands in Food Safety With Petrifilm Feeder Launch
Quest Diagnostics (DGX) Inks Deal to Acquire Allina Health
Charles River (CRL) Inks CDMO Deal With Gates Institutes
Asensus Surgical (ASXC) Announces New Hospital Tie-Up on Senhance
Alcon (ALC) Achieves FDA 510(k) Clearance for Unity VCS and Unity CS
Inspira (IINN) Unveils Business Targets for 2024-25
Thermo Fisher (TMO) Unveils New Research Laboratory in WI
Haemonetics (HAE) Expands VASCADE Line With New Limited Launch
The Joint Corp. Engages Capstone Partners to Accelerate Refranchising Efforts
The Joint Corp. to Participate in Upcoming Investor Conferences
The Joint Corp. (JYNT) Beats Q1 Earnings and Revenue Estimates
The Joint Corp. to Host Conference Call on Thursday, May 2nd to Discuss First Quarter 2024 Results
The Joint Corp. (JYNT) Upgraded to Buy: What Does It Mean for the Stock?
The Joint Corp. (JYNT) Moves 10.1% Higher: Will This Strength Last?
The Joint (JYNT) Rises 30% as Q4 Earnings Beat on Higher Clinics
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- 123.59M
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- 103.94M
- P/E
P/E ratio compares a company's share price to its earnings per share.
- 38.16
- P/B
P/B ratio compares a company's share price to its book value per share.
- 7.99
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 2.18
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- 43.19
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 1.84
- EPS
- 0.23
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 0%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- 46.53
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- 30.42
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- 2.66M
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- 20.94%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- 5.59%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- 0.07
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 5.44
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 5.44
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 2.31
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- 67.37K
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 8.67
Income Statement
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Revenue | 14.82M | 15.17M | 13.38M | 13.27M | 13.08M |
| Gross profit | 12.1M | 12.35M | 10.72M | 10.5M | 10.11M |
| Operating income | 873.67K | 750.31K | 160.92K | -1.14M | -678.53K |
| EBITDA | 1.3M | 1.19M | 623.96K | -714.31K | -288.25K |
| Net income | 1.3M | 991.1K | 855.01K | 93.36K | 967.8K |
| Basic EPS | 0.09 | 0.07 | 0.06 | 0.01 | 0.06 |
| Diluted EPS | 0.09 | 0.07 | 0.06 | 0.01 | 0.06 |
Balance Sheet
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Total assets | 57.92M | 60.97M | 69.39M | 73.18M | 80.09M |
| Total liabilities | 42.43M | 45.89M | 46.66M | 49.92M | 57.26M |
| Total equity | 15.49M | 15.08M | 22.72M | 23.26M | 22.84M |
| Cash & equivalents | 20.68M | 23.6M | 29.7M | 29.81M | 21.92M |
| Current assets | 48.85M | 51.39M | 59.49M | 62.56M | 69.75M |
| Current liabilities | 8.97M | 11.45M | 10.17M | 10.13M | 9.95M |
Cash Flow
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Operating cash flow | -1.48M | 2.9M | 1.77M | 868.65K | -3.7M |
| Investing cash flow | -234.6K | -349.4K | -317.84K | 7.23M | -291.41K |
| Financing cash flow | -1.16M | -8.96M | -1.74M | 0 | 893.18K |
| Change in cash | -2.88M | -6.41M | -286.22K | 8.1M | -3.1M |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | 4 — JOINT Corp | View Filing | |
| edgar index | 4 — JOINT Corp | View Filing | |
| edgar index | 4 — JOINT Corp | View Filing | |
| edgar index | 4 — JOINT Corp | View Filing | |
| edgar index | 8-K — JOINT Corp | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| form 4 | Form 4 — Rubel Matthew E | View Filing | |
| form 4 | Form 4 — Karrmann Sandra R | View Filing | |
| form 4 | Form 4 — DaVella Ronald V | View Filing | |
| form 4 | Form 4 — Grandpre Christopher M | View Filing | |
| edgar index | SCHEDULE 13G/A — JOINT Corp | View Filing | |
| edgar index | 4 — JOINT Corp | View Filing | |
| form 4 | Form 4 — JOBSON CHARLES E | View Filing | |
| form 4 | Form 4 — JOBSON CHARLES E | View Filing | |
| edgar index | 10-Q — JOINT Corp | View Filing | |
| edgar index | 8-K — JOINT Corp | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — JOINT Corp | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — JOINT Corp | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — JOINT Corp | View Filing | |
| edgar index | SCHEDULE 13G/A — JOINT Corp | View Filing | |
| form 4 | Form 4 — JOBSON CHARLES E | View Filing | |
| edgar index | DEF 14A — JOINT Corp | View Filing | |
| edgar index | DEFA14A — JOINT Corp | View Filing | |
| edgar index | SCHEDULE 13G/A — JOINT Corp | View Filing | |
| edgar index | SCHEDULE 13D/A — JOINT Corp | View Filing | |
| edgar index | 10-K — JOINT Corp | View Filing | |
| ten k section | 10-K — business | View Filing | |
| ten k section | 10-K — mda | View Filing | |
| ten k section | 10-K — risk_factors | View Filing | |
| edgar index | 8-K — JOINT Corp | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — JOINT Corp | View Filing | |
| edgar index | 4 — JOINT Corp | View Filing | |
| form 4 | Form 4 — Bowman Scott Justin | View Filing | |
| form 4 | Form 4 — Razdan Sanjiv Kumar | View Filing | |
| edgar index | 4 — JOINT Corp | View Filing | |
| edgar index | 4 — JOINT Corp | View Filing | |
| form 4 | Form 4 — JOBSON CHARLES E | View Filing | |
| form 4 | Form 4 — JOBSON CHARLES E | View Filing | |
| edgar index | 4 — JOINT Corp | View Filing | |
| form 4 | Form 4 — JOBSON CHARLES E | View Filing | |
| form 4 | Form 4 — JOBSON CHARLES E | View Filing | |
| edgar index | 8-K/A — JOINT Corp | View Filing | |
| edgar index | 8-K — JOINT Corp | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — JOINT Corp | View Filing | |
| edgar index | SCHEDULE 13G — JOINT Corp | View Filing | |
| edgar index | SCHEDULE 13D/A — JOINT Corp | View Filing | |
| form 4 | Form 4 — JOBSON CHARLES E | View Filing | |
| edgar index | 4 — JOINT Corp | View Filing | |
| form 4 | Form 4 — JOBSON CHARLES E | View Filing | |
| form 4 | Form 4 — JOBSON CHARLES E | View Filing | |
| edgar index | 8-K — JOINT Corp | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — JOINT Corp | View Filing | |
| form 4 | Form 4 — JOBSON CHARLES E | View Filing | |
| edgar index | 4 — JOINT Corp | View Filing | |
| form 4 | Form 4 — JOBSON CHARLES E | View Filing | |
| edgar index | 4 — JOINT Corp | View Filing | |
| form 4 | Form 4 — JOBSON CHARLES E | View Filing | |
| form 4 | Form 4 — JOBSON CHARLES E | View Filing | |
| edgar index | 3 — JOINT Corp | View Filing | |
| form 3 | Form 3 — JOBSON CHARLES E | View Filing | |
| form 4 | Form 4 — JOBSON CHARLES E | View Filing | |
| edgar index | SCHEDULE 13G/A — JOINT Corp | View Filing | |
| edgar index | 10-Q — JOINT Corp | View Filing | |
| edgar index | 8-K — JOINT Corp | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — JOINT Corp | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | S-8 — JOINT Corp | View Filing | |
| edgar index | 144 — JOINT Corp | View Filing |